An abnormal inflammatory status in the bone marrow microenvironment of myeloproliferative neoplasms (MPNs) has recently been demonstrated; moreover, in chronic myeloid leukemia a downregulated expression of IRF4 has been found. Here, IRF4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.